Descrizione Clinica
Eye Drops Zyal Eye Drops 20f 0.5ml
Z-Yal
Medical device CE.Wet ophthalmic solution and lubricant based on hyaluronic acid salt 0.2%.
Hyaluronic acid thanks to its chemical-physical properties adheres perfectly to the corneal surface and thus allows a profitable hydration and lubrication. Hyaluronic acid is of biotechnological origin and of high molecular weight to confer it high power of adhesion and long time of stay in contact with the cornea. It represents the ideal remedy in case of dryness due to various factors such as stress, dust, fumes, prolonged exposure to sunlight, continuous work to the terminal videos, use of contact lenses.
Composition
Sodium hyaluronate 0.2%; sodium phosphate monobasic monohydrate; sodium phosphate bibasic dodecaidrate; sodium chloride; EDTA biodic bidrato; WFI water.
Instructions for use
Exercise a slight pressure on the body of the monodose bottle.
Apply 1- 2 drops per eye.
You can repeat the operation several times a day as needed.
Warnings
The product is only for external ophthalmic use.
Avoid touching the eye with the tip of the monodose bottle.
Do not use in case of incompatibility notice to any component of the preparation.
Do not use the product after the expiry date indicated on the packaging.
The product must be used within 12 hours of the first opening of the bottle.
Do not disperse the bottle in the environment after use.
Do not store above 25 °C.
Keep the preparation out of the reach of children.
Format
20 monodose fial of 0.5 ml.
Cod. 570.
Bibliography
-Aragonan P. Hyaluronan in the treatment of eye surface disorders. In Chemistry and Biology of Hyaluronan. HG. Gorg and CA Hales (editors). Elsevier ed., 2004:529-551.
-Snlbson GR, Greaves JL, Soper ND, Prjdal JI, wilson CG, Bran AJ. Precorneal residence time of sodium hyaluronate solutions studiese by quantitative range scintigraphy. Eye. 1990;4:594-602.
-Shimmura S, Ono M, Shinozaki K, Toda i, Takamura E, Mashima Y, Tsubota K. Sodium hyaluronate eyedrops in the tratments of dry eye. Br J Ophthalmol. 1995;79(11):1007-1011.
-Aragon P, Micali A, Paladino G, Ferrari F, Puzzolo D. Effects of tear substitute on conjunctival epithelium of mice. Ophthalmic Res. 2007;39(5):265-75. Epub 2007 Sep.12. PubMed PMID: 17851267.
-Milazzo G, Papa V, Aragon P, Russian S, Russian P, Di Bella A. Efficacy of sodium hyaluronate eye drops of different osmolarities in the symptomatic treatment of dry eye patients. Adv Exp Med Biol. 2002;506(Pt B):1233 -5. PubMed PMID: 12 614058.
-Aragon P, Di Stefano G, Ferrare F, Spinella R, Stila A. Sodium Hyaluronate eye drops of different osmolarity for the treatment of eye dry in Slogren's syndrome patients. Br J Ophthalmol. 2002Aug;86(8):879-84. PubMed PMID: 12140209;PubMed Central PMCID: PMC1771217.
-Aragon P, Papa V, Micali A, Santocomo M, Milazzo G. long term treatment with sodium hyaluronate-contayning artificial tears veterans ocular surface clamage in patients whyt dry eye. Br J Ophthalmol. 2002feb;82(2):181-4. PubMed PMID: 11815344; PubMed Central PMCID: PMC1771021.
-Papa V, Aragon P, Russian S, Of Bella A, Russian P, Milazzo G. Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the sympyomatic tratment of dry eye patients. Ophthalmology. 2001 Mar Apr;215(2):124-7. PubMed PMID: 11244343.
